When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CELG - Amgen Pops $2.7 Bln Dose Of Risky Chinese Medicine
Celgene Corporation
By Breakingviews
Amgen's (AMGN) Chinese deal could be good medicine. The pharma giant is paying around $2.7 billion for a 20.5% stake in biotech group BeiGene (BGNE). Splurging on a minority stake in a pre-profit outfit that just fought off a short-seller is hard to stomach. But a partnership promises quick access to China's cancer-drug market at a critical time.
The cash offer of $174.85 per BeiGene ADS represented a 36% premium to the 30-day volume-weighted share price. Investors have reason to question the hefty markup. The Chinese company's net loss widened to almost $700